• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine
  • Human Health News
  • Finance News
  • Microbiome Drug Database
    • About
    • Login/ Register
  • Issue Archive
  • Advertise

Engineering Phage Particles: An Interview with Xavier Duportet, CEO & Co-founder, Eligo Bioscience

July 4, 2019 Microbiome Times Editor's Choice, Pharma & Human Health, Video

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • Enabling the Commercialization of Microbiome Live Biotherapeutic Products with Fit-for-Purpose Cryopreservatives
    November 23, 2021
  • Engineering the Microbiome to Treat Skin Diseases
    November 16, 2021
  • Ferring Presents Complete Data across Five RBX2660 Trials Demonstrating Consistent and Durable Efficacy in Recurrent C. Difficile Infection
    September 30, 2021
  • Microbes turn back the clock as research discovers their potential to reverse aging in the brain
    August 31, 2021
  • Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement
    July 2, 2021
sign up

Sign up to the Microbiome Times newsletter